A new market analysis reveals substantial growth trajectory for the global chronic ocular pain (COP) Industry, underscoring the rising burden of ocular surface disorders worldwide and the urgent unmet need for effective, long-term pain relief solutions. The market, which was valued at USD 3.41 billion in 2024, is projected to expand significantly, reaching USD 5.31 billion by 2032, re... https://www.databridgemarketresearch.com/reports/global-chronic-ocular-pain-market